5GL-99517-85502 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-07
Dose 1 — Pfizer-BioNTech
2021-03-12
Registered in v-safe
2021-03-12
Survey response — days 1–6 daily, dose 1
MedDRA: Diplopia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Third morning after shot I woke with double vision.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-12
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-03-13
Survey response — days 1–6 daily, dose 1
MedDRA: Diplopia — Feeling: Fair · Be unable to do your normal daily activities

Free text: Still having double vision.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-14
Survey response — day 7, dose 1
MedDRA: Diplopia — Feeling: Fair · Be unable to do your normal daily activities

Free text: Still have double vision.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-21
Survey response — day 14, dose 1
MedDRA: Diplopia, Headache — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Double vision is causing headaches.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-21
Report sent to call center — day 14, dose 1
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-03-28
Health check-in — day 21, dose 1
Feeling: Fair

Adult check-in
2021-04-04
Health check-in — day 28, dose 1
Feeling: Fair

Adult check-in
2021-04-11
Health check-in — day 35, dose 1
Feeling: Fair

Adult check-in
2021-04-18
Health check-in — day 42, dose 1
Feeling: Fair

Adult check-in
2021-06-06
Survey response — 3 months, dose 1
MedDRA: Diplopia, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional

Free text: Symptoms: I woke with double vision the third morning after receiving the Phizer shot. About ten weeks later I began regaining my normal vision. Now two weeks later almost full recovery. I believe the problem was due to receiving the shot. · Healthcare visit (other): Appointments with ophthalmologist and nuro ophthalmologist.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-06
Report sent to call center — 3 months, dose 1
Get care from a doctor or other healthcare professional

1 call case(s)
2021-09-05
Health check-in — 6 months, dose 1
Feeling: Good

Adult check-in
2021-12-20
Call 1 — Left Voicemail
2022-03-09
Health check-in — 12 months, dose 1
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-07	Pfizer-BioNTech

Call center

3 call center cases

3 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-12

Systemic reaction (other): Third morning after shot I woke with double vision.

2021-03-13

Systemic reaction (other): Still having double vision.

Release 5 — day 7, dose 1

2021-03-14

Systemic reaction (other): Still have double vision.

Release 6 — day 14, dose 1

2021-03-21

Symptoms: Double vision is causing headaches.

Release 8 — 3 months, dose 1

2021-06-06

Symptoms: I woke with double vision the third morning after receiving the Phizer shot. About ten weeks later I began regaining my normal vision. Now two weeks later almost full recovery. I believe the problem was due to receiving the shot.

Healthcare visit (other): Appointments with ophthalmologist and nuro ophthalmologist.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Unevaluable event	✓	✓	✓
SD	Diplopia	✓	✓	✓
SD	Headache	✓	✓	✓
SRO	Diplopia	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release